<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0120-8748</journal-id>
<journal-title><![CDATA[Acta Neurológica Colombiana]]></journal-title>
<abbrev-journal-title><![CDATA[Acta Neurol Colomb.]]></abbrev-journal-title>
<issn>0120-8748</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Neurología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0120-87482017000100003</article-id>
<article-id pub-id-type="doi">10.22379/24224022122</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Trombólisis intravenosa en pacientes con accidente cerebrovascular isquémico: Experiencia de un Hospital del Caribe Colombiano]]></article-title>
<article-title xml:lang="en"><![CDATA[Intravenous thrombolysis in patients with ischemic stroke: Experience from a Colombian Caribbean Hospital]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Ruiz]]></surname>
<given-names><![CDATA[Eder A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guarín-Navas]]></surname>
<given-names><![CDATA[Erika G.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lora-Acuña]]></surname>
<given-names><![CDATA[Fabián J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Acosta-Reyes]]></surname>
<given-names><![CDATA[Jorge]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Beltrán-Carrascal]]></surname>
<given-names><![CDATA[Elkin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Meza-Cely]]></surname>
<given-names><![CDATA[Nohemí]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2017</year>
</pub-date>
<volume>33</volume>
<numero>1</numero>
<fpage>3</fpage>
<lpage>7</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0120-87482017000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0120-87482017000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0120-87482017000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  INTRODUCCIÓN: Las guías de ACV isquémico establecen dentro del algoritmo de manejo la implementación de la terapia trombolítica intravenosa como una de las estrategias de abordaje del evento agudo que ha demostrado reducir los niveles de discapacidad en los pacientes.  OBJETIVO: Describir el impacto de la realización de trombólisis intravenosa en pacientes con accidente cerebro-vascular isquémico, teniendo como referencia escalas de medición de funcionalidad y pronóstico.  MATERIALES Y MÉTODOS: Se realizó un estudio descriptivo longitudinal en pacientes que recibieron tratamiento fibrinolítico en la Fundación Hospital Universidad del Norte (octubre 2011 - marzo 2016) teniendo en cuenta aspectos demográficos, clínicos, factores de riesgo y seguimiento a los 30 y 90 días para determinar el pronóstico y la mortalidad según escala modificada de Rankin.  RESULTADOS: La población elegible consta de 27 pacientes cuya edad promedio fue de 65 años. La mayor prevalencia se presentó en el género femenino. El factor de riesgo más frecuente fue la hipertensión arterial (19/27). Se realizó manejo inicial de acuerdo al protocolo institucional de la unidad de stroke. Se describen tiempos promedio en cada etapa de la atención médica desde el inicio de los síntomas hasta la realización de la trombolisis. Durante la realización de la intervención terapéutica se documentó las complicaciones que justificaron la suspensión del manejo. Se reportó transformación hemorrágica del ACV y muerte secundaria a ello. La funcionalidad fue valorada con escala NIHSS al ingreso y egreso del paciente, el pronóstico y mortalidad se evaluaron con escala modificada de Rankin, que evidenció que más del 50 % de los pacientes obtuvieron una puntuación entre 0 y 1 a los 90 días postrombólisis.  CONCLUSIONES: El estudio presenta limitantes dadas principalmente por el tamaño de la muestra, pero cabe resaltar que refleja la experiencia de un centro universitario y busca establecer y/o generar una base de datos importante a nivel regional que permita ser punto de referencia y suministrar información para futuros estudios.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[SUMMARY  INTRODUCTION: The ischemic stroke guidelines establish within the management algorithm the implementation of intravenous thrombolytic therapy as one of the strategies to approach the acute event that has been shown to reduce levels of disability in patients.  OBJECTIVE: To describe the impact of intravenous thrombolysis performed on patients with ischemic stroke, taking into account functionality and prognosis measuring scales.  MATERIALS AND METHODS: We conducted a descriptive longitudinal study on patients to whom intravenous thrombolysis were performed at the Fundación Hospital Universidad del Norte ( October 2011 - March 2016) taking into account the demographics aspects as well as risk factors including a 30 and 90 day follow up to determine prognosis and mortality using the modified Rankin scale.  RESULTS: The study consisted of 27 patients whose average age was 65 years, finding a higher prevalence within female patients and A frequent risk factor of hypertension (19/27). Initial management was performed according to the institutional protocol from the stroke unit. Average times were shown at each stage of care, from the onset of symptoms to thrombolysis. During the intervention, some complications were documented which justified the suspension of the treatment. There was hemorrhagic transformation of stroke reported leading to secondary death. Functionality was assessed with the NIHSS scale at patient's admission and discharge, prognosis and mortality were assessed with a modified Rankin scale, which showed that more than 50% of the patients scored between 0 and 1 at 90 days post-thrombolysis.  CONCLUSION: The study has limitations in order to establish conclusions statistically significant, but it does reflect the experience of a university center with an effective therapeutic intervention and looks to create a database in the region that can be use like a reference for other studies.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[accidente cerebrovascular isquémico]]></kwd>
<kwd lng="es"><![CDATA[terapia fibrinolítica]]></kwd>
<kwd lng="es"><![CDATA[Alteplase]]></kwd>
<kwd lng="es"><![CDATA[unidad de stroke]]></kwd>
<kwd lng="en"><![CDATA[Ischemic stroke]]></kwd>
<kwd lng="en"><![CDATA[Fibrinolitic therapy]]></kwd>
<kwd lng="en"><![CDATA[Alteplase]]></kwd>
<kwd lng="en"><![CDATA[Stroke unit]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aho]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Harmsem]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hatano]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Marquardsen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Smirnov]]></surname>
<given-names><![CDATA[V. E]]></given-names>
</name>
<name>
<surname><![CDATA[Strasser]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Cerebrovascular diseases in the community: results of a WHO collaborative study]]></source>
<year>1980</year>
<volume>58</volume>
<page-range>113-30</page-range><publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adult Stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Gentile]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hazinski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation]]></source>
<year>2010</year>
<volume>122</volume>
<numero>18^s3</numero>
<issue>18^s3</issue>
<supplement>3</supplement>
<page-range>S818-28</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Time to treatment with intravenous Alteplase and out-come in stroke an updated pooled analysis of ECASS,ATLANTIS, NIND and EPITHET trials]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Bluhmki]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Von Kumme]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Brott]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
<name>
<surname><![CDATA[Toni]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Grotta]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2010</year>
<volume>375</volume>
<numero>9227</numero>
<issue>9227</issue>
<page-range>1695-703</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Finding the right t-PA dose for Asians with acute ischemic stroke]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sila]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2016</year>
<volume>374</volume>
<page-range>2389-90</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Inclusión de la escala neurológica del National Institute of Health (NIHSS) en la clínica de la unidad de Ictus del Hospital del Mar]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Cient Soc Enfer Neurol]]></source>
<year>2009</year>
<volume>30</volume>
<page-range>15-21</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Trombolisis en el ictus isquémico agudo en centros sin unidad de ictus: ¿derivación a centro de referencia o tratamiento in situ?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Latour-Pérez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Galdos Anuncibay]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Med Intensiva]]></source>
<year>2012</year>
<volume>26</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>324-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Guidelines for the Early Management of Patients With Acute Ischemic Stroke: Guideline for Healthcare Professionals From the American Heart Association/American Stroke. Association]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edward]]></surname>
<given-names><![CDATA[C. Jauch]]></given-names>
</name>
</person-group>
<source><![CDATA[Stroke]]></source>
<year>2013</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>870-947</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Accidentes vasculares cerebrales en la comarca de Osona. Factores de riesgo cardiovascular]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanclemente]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Valdez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[An Med Interna]]></source>
<year>2004</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>161-5</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comportamiento epidemiológico de la enfermedad cerebrovascular en la población colombiana]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Quintero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zarruck]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Col Cardiol]]></source>
<year>2006</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Arana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Zuluaga]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Neurol]]></source>
<year>1997</year>
<volume>25</volume>
<numero>5^s4</numero>
<issue>5^s4</issue>
<supplement>4</supplement>
<page-range>1008-12</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento actual del ataque cerebrovascular isquémico (ACV) agudo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarco]]></surname>
<given-names><![CDATA[L.A.]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Coral]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Univ. Méd]]></source>
<year>2008</year>
<volume>49</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>467-98</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<source><![CDATA[Alcaldía de Soledad - Atlántico [Internet]]]></source>
<year></year>
<publisher-loc><![CDATA[Bogotá, Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Alcaldía de Soledad]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Experiencia de Trombólisis intravenosa en el manejo del ataque cerebro vascular en el Hospital Universitario. San Ignacio 2011-2013 (EXTRO HUSI)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Coral]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Acta Neurol Colomb]]></source>
<year>2014</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>16-21</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Perfil clínico epidemiológico de pacientes con accidente cerebrovascular en el instituto hondu-reño de seguridad social]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Licona]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilera]]></surname>
<given-names><![CDATA[M. Sandoval]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Med Hondur]]></source>
<year>2009</year>
<volume>77</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>99-152</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Experiencia de trombolisis sistematizada en infarto cerebral agudo en un hospital público de Chile]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueroa Reyes]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Med Chile]]></source>
<year>2011</year>
<volume>139</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1118-27</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento con Alteplase en infarto cerebral en la unidad de Stroke (Registro TAICUS)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clementti]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2008</year>
<volume>37</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>41-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[For the ECASS Investigators Thrombolysis with Alteplase 3 to 4*5 hours after acute ischemic stroke]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hacke]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Kaste]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bluhmki]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Brozman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dávalos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Guidetti]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>359</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1317-29</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Thrombolytic Therapy for Acute Stroke - Not a Moment to Lose]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lyden]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>359</volume>
<page-range>1393-5</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Recombinant Tissue Plasminogen Activator (rt-PA) for Stroke The Perspective at 8 Years]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frey]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[The Neurologist]]></source>
<year>2005</year>
<volume>11</volume>
<page-range>123-33</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
